Brief: Conmed Q4 Income From Operations USD 50.187 Million
31/01/2024 21:05
Jan 31 (Reuters) - Conmed Q4 EPS USD 1.05. * Q4 net income USD 33.071 million * Q4 pretax profit USD 40.682 million * Q4 sales USD 327.045 million vs. IBES estimate USD 332.2 million * outlook FY revenue USD 1,340-1,365 million * outlook FY adjusted EPS USD 4.3-4.4
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED